Cargando…
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a complex disease associated with premature mortality. Its diagnosis is challenging, and the identification of biomarkers causally influenced by NAFLD may be clinically useful. We aimed at identifying blood metabolites causally impacted by NAFLD using two...
Autores principales: | Gobeil, Émilie, Maltais-Payette, Ina, Taba, Nele, Brière, Francis, Ghodsian, Nooshin, Abner, Erik, Bourgault, Jérôme, Gagnon, Eloi, Manikpurage, Hasanga D., Couture, Christian, Mitchell, Patricia L., Mathieu, Patrick, Julien, François, Corbeil, Jacques, Vohl, Marie-Claude, Thériault, Sébastien, Esko, Tõnu, Tchernof, André, Arsenault, Benoit J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143809/ https://www.ncbi.nlm.nih.gov/pubmed/35629944 http://dx.doi.org/10.3390/metabo12050440 |
Ejemplares similares
-
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
por: Gagnon, Eloi, et al.
Publicado: (2022) -
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
por: Gagnon, Eloi, et al.
Publicado: (2023) -
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Emilie, et al.
Publicado: (2021) -
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Blood Levels of the SMOC1 Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization Study
por: Ghodsian, Nooshin, et al.
Publicado: (2021)